AU2011249784B2 - Treatment of autoimmune diseases - Google Patents

Treatment of autoimmune diseases Download PDF

Info

Publication number
AU2011249784B2
AU2011249784B2 AU2011249784A AU2011249784A AU2011249784B2 AU 2011249784 B2 AU2011249784 B2 AU 2011249784B2 AU 2011249784 A AU2011249784 A AU 2011249784A AU 2011249784 A AU2011249784 A AU 2011249784A AU 2011249784 B2 AU2011249784 B2 AU 2011249784B2
Authority
AU
Australia
Prior art keywords
amino
pharmaceutically acceptable
acceptable salt
phenyl
benzyloxyphenylthio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2011249784A
Other languages
English (en)
Other versions
AU2011249784A1 (en
Inventor
Peter Gergely
Erik Wallstroem
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42199281&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2011249784(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU2011249784A1 publication Critical patent/AU2011249784A1/en
Application granted granted Critical
Publication of AU2011249784B2 publication Critical patent/AU2011249784B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C321/00—Thiols, sulfides, hydropolysulfides or polysulfides
    • C07C321/24—Thiols, sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/28—Sulfides, hydropolysulfides, or polysulfides having thio groups bound to carbon atoms of six-membered aromatic rings
    • C07C321/30—Sulfides having the sulfur atom of at least one thio group bound to two carbon atoms of six-membered aromatic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2011249784A 2010-05-06 2011-05-05 Treatment of autoimmune diseases Ceased AU2011249784B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10162079 2010-05-06
EP10162079.7 2010-05-06
PCT/EP2011/057203 WO2011138393A1 (en) 2010-05-06 2011-05-05 Treatment of autoimmune diseases

Publications (2)

Publication Number Publication Date
AU2011249784A1 AU2011249784A1 (en) 2012-12-20
AU2011249784B2 true AU2011249784B2 (en) 2014-03-06

Family

ID=42199281

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011249784A Ceased AU2011249784B2 (en) 2010-05-06 2011-05-05 Treatment of autoimmune diseases

Country Status (24)

Country Link
US (1) US20130172297A1 (https=)
EP (1) EP2566470A1 (https=)
JP (1) JP2013530937A (https=)
KR (1) KR20130066630A (https=)
CN (1) CN102869353A (https=)
AU (1) AU2011249784B2 (https=)
BR (1) BR112012028190A2 (https=)
CA (1) CA2795394A1 (https=)
CL (1) CL2012003091A1 (https=)
CR (1) CR20120566A (https=)
CU (1) CU20120154A7 (https=)
EA (1) EA201201514A1 (https=)
EC (1) ECSP12012312A (https=)
IL (1) IL222690A0 (https=)
MA (1) MA34285B1 (https=)
MX (1) MX2012012926A (https=)
NZ (1) NZ603999A (https=)
PE (1) PE20130612A1 (https=)
PH (1) PH12012502418A1 (https=)
SG (1) SG185746A1 (https=)
TN (1) TN2012000509A1 (https=)
TW (1) TW201201814A (https=)
WO (1) WO2011138393A1 (https=)
ZA (1) ZA201207710B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI519539B (zh) * 2010-12-21 2016-02-01 Kyorin Seiyaku Kk Diphenyl sulfide derivatives and pharmaceuticals as an active ingredient thereof
US9289494B2 (en) 2013-11-20 2016-03-22 RestorTears, LLC Method of treating ocular disorders with compounds found in Harderian gland secretions

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1431284A1 (en) * 2001-09-27 2004-06-23 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
EP1431275A1 (en) * 2001-09-27 2004-06-23 Kyorin Pharmaceutical Co., Ltd. Diaryl ether derivative, addition salt thereof, and immunosuppressant
EP1602660A1 (en) * 2003-02-18 2005-12-07 Kyorin Pharmaceutical Co., Ltd. Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101003877B1 (ko) 2002-09-19 2010-12-30 교린 세이야꾸 가부시키 가이샤 아미노알코올 유도체와 그 부가염 및 면역 억제제
JP4716996B2 (ja) * 2003-05-26 2011-07-06 武田薬品工業株式会社 スルホピロール
CN1874996B (zh) 2003-08-28 2011-05-18 诺瓦提斯公司 氨基丙醇衍生物
EP1723138B1 (en) * 2004-02-11 2010-07-14 Basilea Pharmaceutica AG Substituted benzimidazoles and their use for inducing apoptosis
WO2006041015A1 (ja) * 2004-10-12 2006-04-20 Kyorin Pharmaceutical Co., Ltd. アミノアルコール誘導体とその付加塩及び免疫抑制剤
GB0504544D0 (en) * 2005-03-04 2005-04-13 Novartis Ag Organic compounds
SI2295049T1 (sl) * 2005-09-09 2015-03-31 Novartis Ag Zdravljenje avtoimunskih bolezni

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1431284A1 (en) * 2001-09-27 2004-06-23 Kyorin Pharmaceutical Co., Ltd. Diaryl sulfide derivative, addition salt thereof, and immunosuppressant
EP1431275A1 (en) * 2001-09-27 2004-06-23 Kyorin Pharmaceutical Co., Ltd. Diaryl ether derivative, addition salt thereof, and immunosuppressant
EP1602660A1 (en) * 2003-02-18 2005-12-07 Kyorin Pharmaceutical Co., Ltd. Aminophosphonic acid derivatives, addition salts thereof and s1p receptor modulators

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Buzard, DJ (2008) Expert Opin Ther Patents. v18. pp1141-1159 *
Shimizu, H et al (2005) Circulation. v111. pp222-229 *
Wenderfer, SE et al (2008) Kidney International. v74. pp1319-1326 *

Also Published As

Publication number Publication date
CU20120154A7 (es) 2013-03-27
CR20120566A (es) 2013-01-09
PH12012502418A1 (en) 2018-03-21
SG185746A1 (en) 2013-01-30
BR112012028190A2 (pt) 2016-08-02
IL222690A0 (en) 2012-12-31
MX2012012926A (es) 2012-12-17
KR20130066630A (ko) 2013-06-20
ECSP12012312A (es) 2012-12-28
CA2795394A1 (en) 2011-11-10
NZ603999A (en) 2014-06-27
PE20130612A1 (es) 2013-06-06
TN2012000509A1 (en) 2014-04-01
US20130172297A1 (en) 2013-07-04
EA201201514A1 (ru) 2013-05-30
CN102869353A (zh) 2013-01-09
MA34285B1 (fr) 2013-06-01
WO2011138393A1 (en) 2011-11-10
AU2011249784A1 (en) 2012-12-20
JP2013530937A (ja) 2013-08-01
ZA201207710B (en) 2013-06-26
CL2012003091A1 (es) 2013-03-22
TW201201814A (en) 2012-01-16
EP2566470A1 (en) 2013-03-13

Similar Documents

Publication Publication Date Title
US8008286B2 (en) Method for treatment of neuropathic pain
AU2010224355B2 (en) Treatment of autoimmune diseases
KR20110018897A (ko) 수용성 아세트아미노펜 유사체
US20090105315A1 (en) Phenyl-cycloalkyl and phenyl-heterocyclic derivatives as s1p receptor agonists
JP2008530135A (ja) アミノ基およびフェニル基で置換されたシクロアルカンならびに５員の複素環を含むスフィンゴシン＝１−リン酸アゴニスト
JP2010540561A (ja) ベンジル・シクロアルキル・スフィンゴシン１‐リン酸受容体修飾薬
AU2011249784B2 (en) Treatment of autoimmune diseases
US8450318B2 (en) Method to treat infections using anti-infective agents
JP6615247B2 (ja) ジアリールスルフィド誘導体の投与レジメン
US12070448B2 (en) Use of carbamate compound for prevention, alleviation or treatment of status epilepticus
US9181191B2 (en) Heterobicyclic sphingosine 1-phosphate analogs
Rakoczy et al. Salts of α-Amino-p-toluenesulfonamide
HK1160837A (en) Water-soluble acetaminophen analogs

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired